[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:phenylketonuria":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":118,"states":119},"Phenylketonuria",17,15,[8,16,22,29,36,43,49,55,61,68,74,80,86,92,98,104,111],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06971731","A Study of JNT-517 in Participants With Phenylketonuria (PKU)",[12],"Phase 3","RECRUITING","2026-08-26T02:16:03.788292Z","2026-07-19T19:36:05.060353Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06302348","A Study of Sepiapterin in Participants With Phenylketonuria (PKU)",[12],"2026-08-26T02:17:05.997056Z","2026-05-05T02:43:29.328854Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07477691","Immune Modulation During Palynziq® Treatment in Adults (IMPALA)",[26],"Phase 4","2026-08-26T02:16:06.684983Z","2026-05-05T02:43:28.851428Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06332807","AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)",[33],"Phase 1\u002FPhase 2","2026-08-26T02:17:06.985283Z","2026-05-05T02:43:28.295384Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":41,"content_modified":42},"NCT07241234","A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria",[40],"Phase 1","2026-08-26T02:17:30.961790Z","2026-05-05T02:43:28.289455Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT06628128","A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria",[12],"2026-08-26T02:17:24.721169Z","2026-05-05T02:43:27.832722Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT06560736","Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria",[],"2026-08-26T02:19:09.651016Z","2026-05-05T02:43:26.757621Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT01659749","Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria",[],"2026-08-26T02:17:25.718160Z","2026-05-05T02:43:27.812587Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":66,"content_modified":67},"NCT07694440","A Study of MZE782 in Adults With PKU",[65],"Phase 2","2026-08-26T02:17:20.511551Z","2026-07-19T19:36:05.155225Z",{"nct_id":69,"title":70,"phases":71,"status":13,"updated_at":72,"content_modified":73},"NCT06305234","A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)",[],"2026-08-26T02:18:53.782384Z","2026-05-13T02:55:06.433702Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT05813678","A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)",[],"2026-08-26T02:17:36.611194Z","2026-05-13T02:55:06.378047Z",{"nct_id":81,"title":82,"phases":83,"status":13,"updated_at":84,"content_modified":85},"NCT05579548","A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding",[],"2026-08-26T02:15:33.331531Z","2026-05-13T02:55:06.362701Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT04404530","Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)",[],"2026-08-26T02:19:12.219640Z","2026-05-13T02:55:06.247910Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":96,"content_modified":97},"NCT07220265","Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers",[],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:26.687481Z",{"nct_id":99,"title":100,"phases":101,"status":13,"updated_at":102,"content_modified":103},"NCT07194993","PKU Protein Requirements",[],"2026-08-26T02:16:54.044282Z","2026-04-29T02:57:57.128645Z",{"nct_id":105,"title":106,"phases":107,"status":108,"updated_at":109,"content_modified":110},"NCT04348708","Long-Term Follow Up Study of Subjects Previously Administered HMI 102",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:04.914942Z","2026-07-05T18:42:10.723634Z",{"nct_id":112,"title":113,"phases":114,"status":115,"updated_at":116,"content_modified":117},"NCT03655223","Early Check: Expanded Screening in Newborns",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:53:57.297126Z","2026-06-16T05:54:07.977837Z",[],[120,124,128,132,136,139,143,146,149,152,156,159,162],{"state":121,"count":122,"slug":123},"Pennsylvania",8,"pennsylvania",{"state":125,"count":126,"slug":127},"Texas",7,"texas",{"state":129,"count":130,"slug":131},"Indiana",6,"indiana",{"state":133,"count":134,"slug":135},"Georgia",5,"georgia",{"state":137,"count":134,"slug":138},"Oregon","oregon",{"state":140,"count":141,"slug":142},"California",4,"california",{"state":144,"count":141,"slug":145},"Illinois","illinois",{"state":147,"count":141,"slug":148},"Tennessee","tennessee",{"state":150,"count":141,"slug":151},"Utah","utah",{"state":153,"count":154,"slug":155},"Colorado",3,"colorado",{"state":157,"count":154,"slug":158},"Florida","florida",{"state":160,"count":154,"slug":161},"Massachusetts","massachusetts",{"state":163,"count":154,"slug":164},"Wisconsin","wisconsin"]